Type: Cluster Project page: Access page Country: Ireland Synopsis: The CHW Cluster focuses on developing linkages between industry, academia, and government, and ensuring that the right funding mechanisms are in-situ. Our priority is on shared strategies – often called “Co-opetition” – in which companies selectively compete in some respects yet cooperate in other respects.
Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...
Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...
Dates: 01/07/2021 30/06/2026 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITY COLLEGE DUBLIN; NATIONAL UNIVERSITY OF IRELAND; DUBLIN Keywords: psoriasis; arthritis; autoimmunity; skin; drug discovery; machine learning;...
Dates: 01/01/2019 31/12/2024 Topic: Biomarkers identification Project type: Clinic Preclinic Project target: Autoimmune disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: Countries: France; UK; Sweden; Netherlands; Spain; Greece; Ireland; Norway;...
Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...
Dates: 01/04/2018 31/03/2023 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Neurology Colorectal Cancer Digestive disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: NATIONAL UNIVERSITY OF IRELAND GALWAY Keywords: nutrition; microbiote; gut; clinical trial; drug response; model; metabolism; diet; metabolit; colon cancer; Parkinson’s disease; levodopa Countries: Ireland...
Dates: 01/02/2021 31/01/2025 Topic: Tool Project type: Medical Device Project target: Neurology Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: WATERFORD INSTITUTE OF TECHNOLOGY Keywords: RNA; epilepsy; AI; implant; therapeutic; tRNA; neurology; computer cells Countries: Ireland; Denmark; Cyprus; Finland Project page: Access page
Dates: 01/06/2021 31/05/2026 Topic: Training Project type: Preclinic Project target: Neurology Financing: H2020-EU.1.3.4. – Increasing structural impact by co-funding activities Other Participating agents: ROYAL COLLEGE OF SURGEONS IN IRELAND Keywords: entrepeneurship; coronavirus; RNA; neurology; training; COVID-19 Countries: Ireland Project page: Access page
Dates: 22/03/2021 21/03/2024 Topic: Tool Project type: Preclinic Theranostic Project target: Ovarian Cancer Financing: H2020-EU.1.3.2. – Nurturing excellence by means of cross-border and cross-sector mobility Participating agents: DUBLIN CITY UNIVERSITY -COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH Keywords: synthetic biology; tissue engineering; transition metals; oncology; screening; drug resistance; theranostic Countries: Ireland; South Africa Project page: Access...